Apixaban PK pecularities [PK / PD]

posted by BE-proff – 2022-03-14 21:17 (329 d 09:29 ago) – Posting: # 22836
Views: 804

Hi All,

According to Apixaban PIL its kinetics has some peculiarities::lookaround:

1) AUC is 32% higher in patients aged over 65
2) AUC is 18% higher in women
3) AUC is 30% higher in patients with body weight below 50 kilos.

Will it be correct to say (using extrapolation) that if a slim woman aged 70 takes 2.5 mg of apixaban the "actual dose" is close to 5.0 mg? :confused:

From the point of safety the question is important :wink:

Complete thread:

UA Flag
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
24 visitors (0 registered, 24 guests [including 12 identified bots]).
Forum time: 06:47 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz